QUARTZ II-III: Final Efficacy and Safety Results in Patients with HCV Genotype 2 or 3 Infection Treated With Ombitasvir/Paritaprevir/Ritonavir and Sofosbuvir With or Without Ribavirin

Volume
64
Pagination
440A - 440A
ISSN
0270-9139
Metadata
Show full item record
Authors
Shafran, S; Shaw, D; Charafeddine, M; Agarwal, K; Foster, GR; Abunimeh, M; Fu, B; Pilot-Matias, T; Pothacamury, RK; Cohen, E
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/23142
Collections